Aspero Medical announces patent award for their micro-texturing Pillar technology designed to improve outcomes of endoscopy procedures
17 août 2021 10h46 HE
|
Innosphere Ventures
Boulder, Colorado, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup company developing new products for the field of gastroenterology, announced that the United States...
Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors
05 avr. 2021 16h05 HE
|
Metacrine, Inc.
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
29 déc. 2020 10h24 HE
|
Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
Aspero Medical receives $225,000 Grant for development of intraoperative gastrointestinal endoscopic balloon overtube
18 août 2020 11h27 HE
|
Innosphere
Boulder, Colorado, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing solutions and applications for the field of gastroenterology, has received a...
Metacrine to Present at Jefferies 2019 London Healthcare Conference
18 nov. 2019 07h30 HE
|
Metacrine, Inc.
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical announces James Willett as CEO
19 sept. 2019 17h26 HE
|
Innosphere
Boulder, Colorado, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Aspero Medical, University of Colorado Boulder spinoff and Innosphere client company, announced today that James Willett has been appointed...
Metacrine Secures $50 Million Growth Capital Facility from K2 HealthVentures
18 sept. 2019 07h30 HE
|
Metacrine, Inc.
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Aspero Medical Receives Seed Round Investment from Innosphere Fund
04 sept. 2019 15h36 HE
|
Innosphere Fund
Colorado, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Innosphere Fund, a seed-stage venture fund that was formed to accelerate the growth and exit of Innosphere client companies, announced their second...
Metacrine Doses First Patient in 12-Week NASH Proof-of-Concept Trial with a Sustained FXR Agonist
09 juil. 2019 07h30 HE
|
Metacrine, Inc.
SAN DIEGO, July 09, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Metacrine Reports Positive Interim Results with Sustained FXR Agonist in NASH Patients
29 mai 2019 07h30 HE
|
Metacrine, Inc.
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...